1 Institute for Clinical Research and Health Policy Studies and Division of Rheumatology, Tufts-New England Medical Center, 2 Nutrition, Exercise Physiology, and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging Tufts University and 3 Mind-Body Therapies, Boston, MA, USA
Correspondence to: Chenchen Wang, Tufts-New England Medical Center, Box 63, 750 Washington Street, Boston, MA 02111, USA. E-mail: Chenchenw{at}hotmail.com
SIR, Despite extensive clinical trials since 1975 suggesting that regular adequate exercise might play an important role in preventing disability and improving function in patients with rheumatoid arthritis (RA), numerous questions remain about the optimal exercise regimen for patients with RA. For example, joint damage has been observed in RA patients after participation in certain high-impact exercises (such as classic aerobics, strengthening exercises and impact sporting activities) [1]. Recently, American College of Rheumatology (ACR) guidelines have recommended regular physical activity rather than high-intensity exercise [2].
These promising trends in the potential utility of low-impact exercise prompted us to evaluate Tai Chi as a potential complementary therapy for patients with RA. Tai Chi is a traditional Chinese exercise that has been practised for many centuries. Significant improvements in cardiorespiratory function, balance, strength and flexibility, arthritis symptoms, and reduction of pain, stress and anxiety have been reported for a variety of patient populations [3], but the effect of Tai Chi in RA has not been well studied in randomized clinical trials. Thus, the goal of this randomized controlled trial was to conduct a preliminary study to evaluate whether 12 weeks of Tai Chi may be a safe and effective complementary therapy for patients with RA.
The study was approved by the Tufts-New England Medical Center (Tufts-NEMC)/Tufts University Human Investigation Review committee and was conducted in the General Clinical Research Center (GCRC) at Tufts-NEMC. Twenty ambulatory patients with functional class I or II RA were recruited from the outpatient rheumatology clinic at Tufts and randomly assigned to receive Tai Chi (n = 10) or attention control (n = 10) in twice-weekly 1-h group sessions for 12 weeks (Fig. 1). The Tai Chi programme was based on the classical Yang style [4]. The control group was provided with education on nutrition and medical information about RA for 40 min. The final 20 min consisted of stretching exercises involving the upper body, trunk and lower body, each stretch being held for 1015 s.
|
At baseline, the Tai Chi group had significantly worse Health Assessment Questionnaire (HAQ) scores and C-reactive protein (CRP) but were similar in other characteristics (Table 1). At 12 weeks, 5/10 patients (50%) randomized to Tai Chi achieved an ACR 20% response compared with 0/10 (0%) in the control (P = 0.03 in the unadjusted model and P = 0.05 in the adjusted model). Among the five subjects who achieved ACR 20 in Tai Chi group, all had improvement in joint tenderness (2081%), joint swelling (2580%) and physician's global assessment of disease activity (4480%). Four subjects had improvement in pain measurements (2084%), HAQ score (71100%) and CRP (3689%). Two Tai Chi subjects had 20% improvement in almost all the variables in the ACR 20 criteria even without considering the two variables (HAQ and CRP) that were not balanced between the study groups at baseline, and thus could have biased the statistical analysis.
|
This preliminary study suggests that group Tai Chi is a safe and potentially promising complementary therapy for adults with functional class I or II RA. Furthermore, the results demonstrate that Tai Chi seems to be associated with trends to improvement in disease activity that relates to both symptoms of pain and the cognitive coping process, which in turn is related to physical and psychological disability. Our results are consistent with two non-randomized studies of Tai Chi for RA that reported that there was no significant exacerbation of joint symptoms for 10 weeks of Tai Chi [9]. It is also consistent with other Tai Chi studies in which Tai Chi had beneficial effects on tension, anxiety and depression [3].
The study was limited in that the sample size was small and the Tai Chi group appeared to have had more severe RA, as measured by higher HAQ, CRP and tender joint count at baseline and therefore may have had a greater chance for improvement in the outcome measures. The Tai Chi group also weighed less than the controls (Table 1), so we cannot exclude the possibility that Tai Chi may help joint symptoms in non-obese more than in obese individuals. In spite of these limitations, the rigour of the study design and our results warrant further investigation into the potential complementary role of Tai Chi for treatment of RA.
We are grateful to Jennifer Layne, Lynda Burstein, Anne-Marie Fiorino, Christine Botelho, Joni Beshansky, Drs Debra Lerner, Ira Wilson, Elena Massarotti, Nathalie Boileau, Harry Selker, GCRC and Rheumatology clinic nurses for their help with different aspects of the study and to Barbara Tanenbaum, for her expertise in the teaching control group. We gratefully acknowledge the participation of our study subjects, their cooperation, encouragement and enthusiasm was an inspiration to the investigators. This study was supported in part by the General Clinical Research Center (NIH Grant M01-RR0054) and a grant from Tufts-New England Medical Center.
R.R. is an employee of Millenium Pharmaceuticals.
References
|